Open Markets
Business Development

We originate, structure, and operationalize partnerships, from in-/out-licensing to distribution and strategic alliances, so your pipeline and product portfolio translate into durable revenue.

 

Outcomes we drive

• Qualified partner pipelines and faster path to signed agreements

• Better-aligned deal terms via rNPV, IRR, and Monte Carlo scenario support

• Lower execution risk through clear post-signature operating plans

• Cross-border readiness (Canada/U.S.) with regulatory and access alignment

 

What we deliver

• Search & Origination: longlist/shortlist, KOL/market signals, and outreach

• Evaluation & Diligence: clinical, regulatory, commercial, and ops fit

• Deal Structuring: valuation ranges, scenario models, and term-sheet support

• Routes-to-Market: distributor, GPO/IDN, specialty pharmacy/PSP alignment

• Operating Plan: governance, milestones, and handoff to sales/marketing

 

Motions we support (the what, not the how)

• In-/out-licensing, co-promotion, and co-development

• Cross-border entry (Canada↔U.S, EU.)

• Pharma, Biotech, AI/AI Health, Medical Device, MedTech/IVD, Diagnostics, Surgical and SaMD

• Hospital/IDN partnerships and evaluation programs

• Government/innovation programs alignment where appropriate

 

Artifacts you get

• Deal pipeline and partner scorecards

• Data room checklist and diligence tracker

• Valuation workbook (rNPV, IRR, PoS; scenario bands)

• Term-sheet templates and negotiation issues list

• BOT transition plan into commercial operations

 

Engagement models

• Sprint (2–4 weeks): landscape + shortlist + valuation ranges

• Build (6–12 weeks): outreach, diligence, and term-sheet support

• Build–Operate–Transfer (BOT): we originate, close, and operationalize; then transfer

• Custom - Time and project tailored designed for your needs

​

​Common Guardrails 

• Regulatory-first: compliance built into content, field interactions, and partnerships

• Investor-ready: board-grade metrics and reporting cadence

• Clarity AI™ (HITL): simulations and thresholds for decisions under uncertainty

• Stage-fit: startup to enterprise; flexible resourcing and clear handoffs

 

Who we help

Pharma, Biotech, AI/AI Health, Medical Device, MedTech/IVD, Diagnostics, Surgical and SaMD from Seed to Series C, SMB units, enterprise BUs, and investors.

​​

Book a 30‑minute strategy call

 

See the Competitive Advantage 

​​